Free Trial

PROCEPT BioRobotics (PRCT) Competitors

PROCEPT BioRobotics logo
$59.34 -0.73 (-1.21%)
As of 12:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

PRCT vs. SOLV, PEN, STVN, GKOS, BLCO, IRTC, SLNO, TMDX, INSP, and NVST

Should you be buying PROCEPT BioRobotics stock or one of its competitors? The main competitors of PROCEPT BioRobotics include Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), iRhythm Technologies (IRTC), Soleno Therapeutics (SLNO), TransMedics Group (TMDX), Inspire Medical Systems (INSP), and Envista (NVST). These companies are all part of the "medical equipment" industry.

PROCEPT BioRobotics vs. Its Competitors

Solventum (NYSE:SOLV) and PROCEPT BioRobotics (NASDAQ:PRCT) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.

Solventum has a net margin of 4.55% compared to PROCEPT BioRobotics' net margin of -36.20%. Solventum's return on equity of 31.01% beat PROCEPT BioRobotics' return on equity.

Company Net Margins Return on Equity Return on Assets
Solventum4.55% 31.01% 6.53%
PROCEPT BioRobotics -36.20%-28.09%-20.02%

In the previous week, Solventum had 1 more articles in the media than PROCEPT BioRobotics. MarketBeat recorded 12 mentions for Solventum and 11 mentions for PROCEPT BioRobotics. Solventum's average media sentiment score of 1.05 beat PROCEPT BioRobotics' score of 1.01 indicating that Solventum is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Solventum
8 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
PROCEPT BioRobotics
7 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Solventum has higher revenue and earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Solventum$8.25B1.56$478M$2.1634.42
PROCEPT BioRobotics$224.50M14.62-$91.41M-$1.70-34.90

Solventum has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500. Comparatively, PROCEPT BioRobotics has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500.

89.5% of PROCEPT BioRobotics shares are held by institutional investors. 0.1% of Solventum shares are held by insiders. Comparatively, 6.6% of PROCEPT BioRobotics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Solventum presently has a consensus target price of $84.38, indicating a potential upside of 13.50%. PROCEPT BioRobotics has a consensus target price of $84.13, indicating a potential upside of 41.78%. Given PROCEPT BioRobotics' stronger consensus rating and higher possible upside, analysts clearly believe PROCEPT BioRobotics is more favorable than Solventum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Solventum
1 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.27
PROCEPT BioRobotics
0 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.78

Summary

Solventum beats PROCEPT BioRobotics on 9 of the 16 factors compared between the two stocks.

Get PROCEPT BioRobotics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRCT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PRCT vs. The Competition

MetricPROCEPT BioRoboticsMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$3.29B$6.89B$5.68B$9.50B
Dividend YieldN/A1.30%4.05%3.99%
P/E Ratio-34.9925.4627.9520.00
Price / Sales14.6262.47397.1083.19
Price / CashN/A20.2736.1958.45
Price / Book7.704.768.665.83
Net Income-$91.41M$176.14M$3.24B$258.39M
7 Day Performance0.69%2.07%3.33%2.30%
1 Month Performance0.69%4.04%10.84%12.42%
1 Year Performance-12.03%7.28%35.32%21.16%

PROCEPT BioRobotics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PRCT
PROCEPT BioRobotics
2.7855 of 5 stars
$59.34
-1.2%
$84.13
+41.8%
-13.5%$3.29B$224.50M-34.99430Positive News
SOLV
Solventum
0.9719 of 5 stars
$74.08
+0.4%
$81.50
+10.0%
+31.4%$12.82B$8.25B34.3022,000Positive News
PEN
Penumbra
4.613 of 5 stars
$238.82
+0.4%
$305.07
+27.7%
+24.2%$9.25B$1.24B225.314,500Positive News
Upcoming Earnings
STVN
Stevanato Group
1.4013 of 5 stars
€25.55
+1.3%
N/A+18.1%€7.74B€1.12B50.105,521Gap Up
GKOS
Glaukos
4.4749 of 5 stars
$104.43
+0.6%
$134.67
+29.0%
-23.4%$5.97B$404.52M-44.06780Positive News
Upcoming Earnings
BLCO
Bausch + Lomb
2.1916 of 5 stars
$13.67
-1.5%
$15.45
+13.1%
-16.3%$4.83B$4.83B-13.2713,500News Coverage
Upcoming Earnings
IRTC
iRhythm Technologies
1.2872 of 5 stars
$138.91
+2.2%
$138.60
-0.2%
+34.4%$4.43B$591.84M-44.242,000Positive News
Upcoming Earnings
SLNO
Soleno Therapeutics
3.8025 of 5 stars
$82.76
+1.5%
$108.70
+31.3%
+80.7%$4.17BN/A-17.9130Positive News
TMDX
TransMedics Group
2.3666 of 5 stars
$116.88
+3.9%
$127.33
+8.9%
-29.2%$3.95B$441.54M85.94210Positive News
Upcoming Earnings
INSP
Inspire Medical Systems
4.9082 of 5 stars
$130.17
-0.1%
$211.91
+62.8%
-5.3%$3.84B$802.80M59.981,246Positive News
Analyst Forecast
NVST
Envista
3.5309 of 5 stars
$20.05
-0.8%
$20.23
+0.9%
+27.8%$3.40B$2.51B-3.0712,300Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:PRCT) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners